National Institute of Health (NIH) is a medical research center with 27 institutes found in the US Department of Health and Human Services. It conducts and supports basic clinical and transitional medical research, where the investigation of both common and rare disease’s causes, treatment, and cures are done. Under its umbrella is the National Institute of Allergy and Infectious Diseases (NIAID) that sponsored a trial called HALT-MS where researchers examined the effectiveness, safety, as well as the durability of HDIT/HCT in twenty-four individuals aged between 26-52 years going through the relapse of MS symptoms.
The volunteers did not take any MS treatments after receiving a high-dose of immunosuppressive treatment and autologous hematopoietic cell transplant (HDIT/HCT. It was discovered that one treatment with HDIT/HCT is more effective than continuing treatment with the best medicines available. NIAD Director Anthony S Fausi indicated that the encouraging findings support further research to establish the effectiveness of HALT-MS.The experimental treatment is after suppressing active disease-causing cells and resetting the immune system. Five years later, those who participated remained in remission and their MS stabilized. Some showed improvement of recovery of mobility. HDIT/HCT will be the possible therapeutic alternative for patients suffering from active relapsing-remitting MS especially those who respond poorly to the available therapies. You can also visit his Facebook profile : https://www.facebook.com/shivagopalvasishta
Dr. Shiva Goal Visishta has close to 40 years of experience in the field of Neurology because he started practicing immediately after graduating in 1979 from Government Medical College. He is also specialized in psychiatry and is a member of the Eastern Neurodiagnostic Associates.Dr. Shiva is licensed to operate in New Jersey and participates in Medicare programs. He accepts multiple insurance plans. He is a board certified Neurologist who speaks English and Spanish. Dr. Shiva is part of the National Institute of Health through his Area of specialty.